NCT01176058 - A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Candidemia

Interventions

DRUG

Anidulafungin/Fluconazole

Anidulafungin:IV,100 mg daily preceded by an initial 200 mg dose on Day 1, 14 - 42 days Fluconazole: IV/Oral, 400mg,QD,14 - 42 days

Trial Locations (7)

Peking Union Medical College Hospital / Department of Infectious Disease, Beijing

Institute of Antibiotics, Hua Shan Hospital, Fudan University, Shanghai

Changhai Hospital, Hemotology Department, Shanghai

Nanjing General Hospital of Nanjing Military Command/Respiratory Department, Nanjing

The First Affiliated Hospital of Medical School of Zhejiang University/Department of Hematology, Hangzhou

Sir run run shaw hospital, Affiliated with school of medicine, Zhejiang University, Hangzhou

Nanfang Hospital, Guangzhou